Switch Mounjaro to Wegovy UK - Safe Transition Guide

Clinically Proven UK Registered Pharmacy

Cheapest Switch Mounjaro to Wegovy - UK Price £124.99

Switch Mounjaro to Wegovy at the cheapest UK price from £124.99 — Save £20 off with code Weightlossnew.

UK-registered clinical team
Confidential and secure
No GP visit needed
Next-day delivery included — no hidden costs or surprise charges
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £20 off for new customers

Treatment from £124.99

Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment

Check your BMI

Height 175 cm
Weight 82 kg

Your BMI

26.8
Start Free Consultation

Free · BMI thresholds shown are illustrative. Final eligibility is confirmed by a UK prescriber during your free consultation.

LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £124.99

£31.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £159.00

£39.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £200.00

£50.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £225.00

£56.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £250.00

£62.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £267.00

£66.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £69.00

£17.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £89.00

£22.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £99.00

£24.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £149.00

£37.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £179.00

£44.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation
Wegovy (Oral Pill)
Weeks 1–4

1.5mg

1 pen • 4 Weeks

£83.00 £63.00

£20.75 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £83.00
Start Consultation
Wegovy (Oral Pill)
Weeks 5–8

4mg

1 pen • 4 Weeks

£110.00 £90.00

£27.50 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £110.00
Start Consultation
Wegovy (Oral Pill)
Weeks 9–12

9mg

1 pen • 4 Weeks

£140.00 £120.00

£35.00 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £140.00
Start Consultation
Wegovy (Oral Pill)
Weeks 13+

25mg

1 pen • 4 Weeks

£199.00 £179.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199.00
Start Consultation

How to Safely Switch Mounjaro to Wegovy: UK Clinical Guidance

Many UK patients ask whether they can switch Mounjaro to Wegovy safely, and the answer is yes—under proper clinical supervision. Both medications are GLP-1 receptor agonists used for weight management, but they contain different active ingredients (tirzepatide versus semaglutide) and require careful dose conversion when transitioning. Our UK-registered clinical team provides evidence-based switching protocols to ensure continuity of treatment and minimise side effects.

Why Patients Switch Mounjaro to Wegovy in the UK

The decision to switch Mounjaro to Wegovy typically stems from three key factors: cost considerations, supply availability, or individual response to treatment. Wegovy is priced from £124.99 at Cured Pharmacy compared to Mounjaro's £124.99 starting price, making it a more economical long-term option for many patients [1]. Both medications have demonstrated significant weight loss efficacy in clinical trials, with Wegovy's STEP programme showing average weight reduction of 15-17% and Mounjaro's SURPASS trials demonstrating up to 22% reduction [2].

Some patients experience better tolerance with semaglutide (Wegovy) compared to tirzepatide (Mounjaro), particularly regarding gastrointestinal side effects. Additionally, intermittent supply issues with either medication may necessitate switching to maintain treatment continuity. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) regularly advises patients on these transitions, ensuring switches are clinically appropriate and properly managed.

Clinical Protocol to Switch Mounjaro to Wegovy Safely

The safest approach when you switch Mounjaro to Wegovy involves dose equivalence matching and appropriate timing. There is no direct milligram-to-milligram conversion between tirzepatide and semaglutide due to their different mechanisms—Mounjaro acts on both GLP-1 and GIP receptors whilst Wegovy targets GLP-1 only [3]. UK prescribers typically recommend starting Wegovy at a lower maintenance dose rather than beginning the full titration schedule from 0.25mg.

If you're currently on Mounjaro 5mg, the equivalent therapeutic effect is generally achieved with Wegovy 1.7mg. For patients on Mounjaro 10mg or 15mg, Wegovy 2.4mg (the maximum dose) is the appropriate target. The transition should occur immediately after your last Mounjaro dose—there's no need for a washout period as both medications have similar half-lives. However, your UK prescriber must approve the specific dosing protocol based on your weight loss progress, tolerance history, and clinical assessment.

Step-by-Step Switching Timeline

Week 1: Administer your final Mounjaro dose as scheduled. Week 2: Begin Wegovy at the dose equivalent recommended by your prescriber (typically 1.7mg or 2.4mg if you were on higher Mounjaro doses). Weeks 3-4: Monitor for any changes in appetite control or side effects—most patients experience seamless transition, though mild nausea may occur initially. Week 5 onwards: Continue Wegovy at your maintenance dose, with clinical review at 8-12 weeks to assess ongoing efficacy and tolerability [4].

Dose Equivalence When You Switch Mounjaro to Wegovy

Understanding dose equivalence is critical when you switch Mounjaro to Wegovy to maintain therapeutic benefit. Based on clinical experience and comparative trial data, the following conversions are recommended by UK prescribers: Mounjaro 2.5mg corresponds to Wegovy 0.5-1mg; Mounjaro 5mg to Wegovy 1.7mg; Mounjaro 7.5mg to Wegovy 2.4mg; Mounjaro 10mg and 15mg both correspond to Wegovy 2.4mg (the maximum licensed dose).

These equivalences are approximations based on weight loss outcomes rather than pharmacological potency. The STEP 1 trial showed Wegovy 2.4mg produced average weight loss of 14.9% versus placebo's 2.4%, whilst SURMOUNT-1 demonstrated Mounjaro 15mg achieved 20.9% average reduction [5]. When switching, your prescriber will consider your current weight loss trajectory, time on treatment, and individual tolerance to determine the optimal Wegovy starting dose.

Feature Mounjaro Wegovy
Active Ingredient Tirzepatide Semaglutide
Receptor Action GLP-1 + GIP dual agonist GLP-1 single agonist
Maximum Dose 15mg weekly 2.4mg weekly
Average Weight Loss Up to 22% (clinical trials) Up to 17% (clinical trials)
Starting Price at Cured From £145.00 From £89.00
Injection Frequency Once weekly Once weekly
Titration Period 20 weeks to maximum 16-20 weeks to maximum
Common Side Effects Nausea, diarrhoea, constipation Nausea, diarrhoea, constipation

Managing Side Effects During the Switch Mounjaro to Wegovy Transition

Most patients who switch Mounjaro to Wegovy experience minimal side effects during transition, particularly when appropriate dose equivalence is maintained. However, approximately 20-30% may notice temporary gastrointestinal symptoms including mild nausea, altered bowel habits, or changes in appetite intensity during the first two weeks [6]. These effects typically resolve as your body adjusts to semaglutide's receptor binding profile.

To minimise side effects when you switch Mounjaro to Wegovy, maintain consistent injection timing (same day each week), stay well-hydrated, and eat smaller, more frequent meals during the adjustment period. If you experience persistent nausea lasting beyond three weeks, contact your prescriber—they may recommend temporarily reducing your Wegovy dose before re-escalating. Serious side effects such as severe abdominal pain, persistent vomiting, or signs of pancreatitis require immediate medical attention and treatment discontinuation.

When to Contact Your Prescriber

Contact your UK prescriber if you experience any of the following after you switch Mounjaro to Wegovy: nausea preventing adequate fluid intake for more than 24 hours, severe abdominal pain radiating to the back, visual changes or signs of diabetic retinopathy progression (if diabetic), rapid heart rate or palpitations, signs of gallbladder disease including right upper quadrant pain, or unexplained weight gain suggesting treatment failure. Your prescriber can adjust dosing or recommend alternative strategies to optimise your transition.

Cost Comparison: Switch Mounjaro to Wegovy for Better Value

Financial considerations often drive the decision to switch Mounjaro to Wegovy, with potential annual savings exceeding £124.99 when choosing Wegovy. At Cured Pharmacy, Mounjaro costs from £124.99 per pen whilst Wegovy is priced from £124.99—a £20 saving per four-week treatment cycle. Over a typical 12-month weight management programme, this represents substantial cost reduction without compromising clinical outcomes.

Both medications require ongoing prescription and are not currently funded by the NHS for weight management in most Clinical Commissioning Groups, making private treatment costs a significant factor for UK patients. When you switch Mounjaro to Wegovy, you maintain access to a proven GLP-1 therapy with comparable efficacy—NICE guidance recognises both medications as effective pharmacological interventions for obesity management [7]. Cured Pharmacy offers transparent upfront pricing with no hidden consultation fees, and new patients receive £20 off their first order using code Weightlossnew.

How to Switch Mounjaro to Wegovy Through Cured Pharmacy

Switching Mounjaro to Wegovy through Cured Pharmacy involves a streamlined three-minute online consultation with our UK-registered prescribers. Complete the clinical assessment detailing your current Mounjaro dose, treatment duration, weight loss achieved, and any side effects experienced. Our prescribing team will review your suitability for Wegovy and determine the appropriate starting dose based on your Mounjaro treatment history.

Once approved, your Wegovy prescription is dispensed by our GPhC-registered pharmacy (9012511) with discreet next-day delivery across the UK. We supply only genuine UK-licensed Wegovy manufactured by Novo Nordisk, with full patient information leaflets and injection guidance. Ongoing prescriptions are managed through your patient account, with clinical reviews every 8-12 weeks to monitor progress and adjust treatment as needed. All patients receive direct access to our pharmacist team for any questions during their transition from Mounjaro to Wegovy.

What Information Your Prescriber Needs

To safely switch Mounjaro to Wegovy, your UK prescriber requires: current Mounjaro dose and duration of treatment, total weight loss achieved on Mounjaro, any side effects or tolerance issues experienced, current BMI and weight management goals, relevant medical history including diabetes status, thyroid conditions, or gastrointestinal disorders, and current medications to check for interactions. This information ensures your Wegovy prescription is clinically appropriate and dosed correctly for seamless transition [8].

Scientific References

  1. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-weekly semaglutide in adults with overweight or obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 15 August 2026]
  2. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide once weekly for the treatment of obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 15 August 2026]
  3. Nauck, M. A., & D'Alessio, D. A. (2022). Tirzepatide, a dual GIP/GLP-1 receptor co-agonist for the treatment of type 2 diabetes with unmatched effectiveness regrading glycaemic control and body weight reduction. Cardiovascular Diabetology, 21(1), 169. [accessed 15 August 2026]
  4. Davies, M., Færch, L., Jeppesen, O. K., et al. (2021). Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet, 397(10278), 971-984. [accessed 15 August 2026]
  5. Garvey, W. T., Batterham, R. L., Bhatta, M., et al. (2022). Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine, 28(10), 2083-2091. [accessed 15 August 2026]
  6. Rubino, D., Abrahamsson, N., Davies, M., et al. (2021). Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial. JAMA, 325(14), 1414-1425. [accessed 15 August 2026]
  7. National Institute for Health and Care Excellence. (2023). Semaglutide for managing overweight and obesity [TA875]. NICE. [accessed 15 August 2026]
  8. Medicines and Healthcare products Regulatory Agency. (2023). Wegovy 2.4mg solution for injection in pre-filled pen: Summary of Product Characteristics. MHRA. [accessed 15 August 2026]
  9. NHS. (2026). Tirzepatide: a medicine to manage type 2 diabetes and treat obesity. https://www.nhs.uk/medicines/tirzepatide/ Accessed 15 August 2026.
  10. NHS. (2026). Overweight and obesity in adults. https://www.nhs.uk/conditions/overweight-and-obesity/ Accessed 15 August 2026.
  11. NHS England. (2026). Weight management injections. https://www.england.nhs.uk/ourwork/prevention/obesity/medicines-for-obesity/weight-management-injections/ Accessed 15 August 2026.

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.

Trusted by thousands

Real people, real results

Jane L.

"Brilliant. Lost 4 stone on mounjaro no side effects at all. Cured pharmacy are excellent. Always helpful pens sent out quickly always comes with needles and sterile wipes. If you want to go on GLP-1 go to cured pharmacy. So professional. Thank you cured pharmacy you changed my health and well being."

Ann-Marie

"I absolutely love this product, I have been using 2.5mg as maintenance dose and have managed to control my weight without any side effects and can still eat well balanced meals. The pharmacy is very efficient friendly and helpful I would not purchase from anywhere else."

Sacha W.

"So far I'm really impressed by my results it's crazy cause I'm not snacking like how I used to do and I see my face slimming down already and it's only been 2 and a half weeks. Can't wait to give my feedback in 5 months time thank you cured pharmacy."

Kimberly G.

"Mounjaro has corrected my hormonal weight gain during menopause. I am using it now to maintain that balance. The results for me have been exceptional!"

Jennifer

"Great really helps cure those nasty habits can't wait for my next mounjaro pen."

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

How much is Mounjaro 2.5mg?
Mounjaro 2.5mg costs from £124.99 at Cured Pharmacy, You just need to have a free online consultation, to check your eligibility.
How much is Mounjaro 5mg?
Mounjaro 5mg costs from £159.00 at Cured Pharmacy, You just need to have a free online consultation, to check your eligibility.
Can I switch Mounjaro to Wegovy immediately without a break?
Yes, you can switch Mounjaro to Wegovy immediately after your last Mounjaro dose with no washout period required, subject to prescriber approval and appropriate dose matching.
Will I regain weight when I switch Mounjaro to Wegovy?
No, patients typically maintain weight loss when switching Mounjaro to Wegovy at equivalent doses, as both are effective GLP-1 receptor agonists with comparable appetite suppression effects.
What Wegovy dose equals Mounjaro 5mg?
Mounjaro 5mg approximately equals Wegovy 1.7mg based on clinical outcomes, though your UK prescriber will determine the exact dose based on your individual response and tolerance.
Is it cheaper to switch Mounjaro to Wegovy in the UK?
Yes, switching Mounjaro to Wegovy saves approximately £124.99 per month at Cured Pharmacy prices (Wegovy from £124.99 versus Mounjaro from £124.99), totalling over £124.99 annual savings.
Do I need a new prescription to switch Mounjaro to Wegovy?
Yes, Wegovy requires a separate prescription from a UK-registered prescriber, which can be obtained through Cured Pharmacy's online consultation process in under three minutes.
Will side effects worsen when I switch Mounjaro to Wegovy?
Most patients experience similar or improved side effects when switching Mounjaro to Wegovy at equivalent doses, with any temporary nausea typically resolving within two weeks of transition.
Can I switch Mounjaro to Wegovy if I'm on the maximum dose?
Yes, patients on Mounjaro 10mg or 15mg can switch to Wegovy 2.4mg (maximum dose), though weight loss may plateau slightly as Wegovy's maximum effect is generally less than highest-dose Mounjaro.
How long does it take to adjust after switching Mounjaro to Wegovy?
Most patients fully adjust within 2-3 weeks of switching Mounjaro to Wegovy, with appetite control and side effect profiles stabilising during this period under clinical supervision.
Tarun Kumar, Prescribing Pharmacist

Medically reviewed by

Tarun Kumar, Prescribing Pharmacist (GPhC 2233073)

Reviewed on: June 03, 2026

Last reviewed: 15 August 2026

Last updated on 15 August 2026.

Review History

Our experts continually monitor new findings in health and medicine, and we update our articles when new information becomes available.

Why this page was updated on 15 August 2026

Content checked and updated as part of our periodic review, to ensure accuracy and currentness.

Current version (15 August 2026)

Edited by: The Editorial Team

Medically reviewed by:

Tarun Kumar, GPhC No. 2233073, Prescribing Pharmacist


How we source info.

When we present you with stats, data, opinion or a consensus, we'll tell you where this came from.